| 1 |
32768351 | Comparing the Diagnostic Performance of Multiparametric Prostate MRI Versus 68Ga-PSMA PET-CT in the Evaluation Lymph Node Involvement and Extraprostatic Extension. | 2022 May |
1 |
| 2 |
34400066 | How accurate is 68Gallium-prostate specific membrane antigen positron emission tomography / computed tomography (68Ga-PSMA PET/CT) on primary lymph node staging before radical prostatectomy in intermediate and high risk prostate cancer? A study of patient- and lymph node- based analyses. | 2022 Jan |
1 |
| 3 |
34559264 | Radiomics for detecting prostate cancer bone metastases invisible in CT: a proof-of-concept study. | 2022 Mar |
1 |
| 4 |
34648046 | Ga-68 PSMA PET/CT in recurrent high-grade gliomas: evaluating PSMA expression in vivo. | 2022 May |
1 |
| 5 |
35166426 | Standardised uptake values as determined on prostate-specific membrane antigen positron emission tomography/computed tomography is associated with oncological outcomes in patients with prostate cancer. | 2022 Jun |
2 |
| 6 |
35191735 | Safety and Diagnostic Yield of 68Ga Prostate-specific Membrane Antigen PET/CT-guided Robotic-assisted Transgluteal Prostatic Biopsy. | 2022 May |
2 |
| 7 |
35229224 | Comparison of 68Ga-PSMA PET/CT with fluoride PET/CT for detection of bone metastatic disease in prostate cancer. | 2022 Mar 1 |
1 |
| 8 |
35399427 | Gallium-68 Prostate-Specific Membrane Antigen Positron Emission Tomography: A Practical Guide for Radiologists and Clinicians. | 2022 Mar |
2 |
| 9 |
35584444 | Accuracy of 68Ga-PSMA PET-CT and PET-MRI in lymph node staging for localized prostate cancer. | 2022 |
1 |
| 10 |
31227464 | Positron Emission Tomography/Computed Tomography with Gallium-68-labeled Prostate-specific Membrane Antigen Detects Relapse After Vascular-targeted Photodynamic Therapy in a Prostate Cancer Model. | 2021 Mar |
1 |
| 11 |
32826958 | Diagnostic ability of Ga-68 PSMA PET to detect dominant and non-dominant tumors, upgrading and adverse pathology in patients with PIRADS 4-5 index lesions undergoing radical prostatectomy. | 2021 Mar |
1 |
| 12 |
32863189 | Metastasis-directed Therapy (SBRT) Guided by PET-CT 18F-CHOLINE Versus PET-CT 68Ga-PSMA in Castration-sensitive Oligorecurrent Prostate Cancer: A Comparative Analysis of Effectiveness. | 2021 Jun |
1 |
| 13 |
32979229 | Impact of 68 Gallium prostate-specific membrane antigen tracers on the management of patients with prostate cancer who experience biochemical recurrence. | 2021 Feb |
1 |
| 14 |
32980380 | Comment on: Role of 68-Ga-PSMA-PET/CT in pelvic radiotherapy field definitions for lymph node coverage in prostate cancer patients, by Onal C et al. | 2021 Feb |
1 |
| 15 |
33186177 | Comparison of MRI, PSMA PET/CT, and Fusion PSMA PET/MRI for Detection of Clinically Significant Prostate Cancer. | 2021 Mar-Apr 01 |
1 |
| 16 |
33459068 | Inhibitors of prostate-specific membrane antigen in the diagnosis and therapy of metastatic prostate cancer - a review of patent literature. | 2021 Jun |
1 |
| 17 |
33746213 | Evolving role of 225Ac-PSMA radioligand therapy in metastatic castration-resistant prostate cancer-a systematic review and meta-analysis. | 2021 Sep |
1 |
| 18 |
33850501 | Oligometastasis to testis in prostate cancer: Role of gallium-68 prostate-specific membrane antigen positron-emission tomography computed tomography. | 2021 Jan-Mar |
1 |
| 19 |
33931929 | Diagnostic accuracy of 68 Ga-PSMA PET/MRI and multiparametric MRI in detecting index tumours in radical prostatectomy specimen. | 2021 Aug |
1 |
| 20 |
33946599 | Preclinical Assessment Addressing Intravenous Administration of a [68Ga]Ga-PSMA-617 Microemulsion: Acute In Vivo Toxicity, Tolerability, PET Imaging, and Biodistribution. | 2021 Apr 30 |
1 |
| 21 |
33948339 | Intracranial Metastasis from Prostate Cancer: Investigation, Incidence, and Imaging Findings in a Large Cohort of Australian Men. | 2021 |
1 |
| 22 |
33996472 | 68Ga-PSMA PET/CT versus CT and bone scan for investigation of PSA failure post radical prostatectomy. | 2021 Apr |
1 |
| 23 |
34021667 | PET/CT using 68 Ga-PSMA-617 versus 18 F-fluorodeoxyglucose to differentiate low- and high-grade gliomas. | 2021 Jul |
2 |
| 24 |
34108764 | 68Ga-PSMA PET/CT: effect of external cooling on salivary gland uptake. | 2021 May-Jun |
1 |
| 25 |
34321974 | A case of hepatic focal nodular hyperplasia mimicking hepatocellular carcinoma identified on gallium-68-prostate-specific membrane antigen positron emission tomography/computed tomography. | 2021 Apr-Jun |
2 |
| 26 |
34463555 | Diagnostic Performance of 68Ga Prostate-specific Membrane Antigen PET/MRI Compared with Multiparametric MRI for Detecting Clinically Significant Prostate Cancer. | 2021 Nov |
3 |
| 27 |
34643830 | On site production of [18F]PSMA-1007 using different [18F]fluoride activities: practical, technical and economical impact. | 2021 Oct 13 |
1 |
| 28 |
34658547 | Comparison of Multiparametric Magnetic Resonance Imaging and Gallium-68 Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography for Detecting Carcinoma Prostate in Patients with Serum Prostate-Specific Antigen between 4 and 20 ng/ml. | 2021 Jul-Sep |
1 |
| 29 |
34672630 | Synthesis and Preclinical Evaluation of [18F]SiFA-PSMA Inhibitors in a Prostate Cancer Model. | 2021 Nov 11 |
2 |
| 30 |
34725194 | Improving Theranostic Gallium-68/Lutetium-177-Labeled PSMA Inhibitors with an Albumin Binder for Prostate Cancer. | 2021 Dec |
1 |
| 31 |
34830843 | Prostate-Specific Membrane Antigen in Anaplastic and Poorly Differentiated Thyroid Cancer-A New Diagnostic and Therapeutic Target? | 2021 Nov 14 |
1 |
| 32 |
34832889 | Initial Experience of Clinical Use of [99mTc]Tc-PSMA-T4 in Patients with Prostate Cancer. A Pilot Study. | 2021 Oct 29 |
1 |
| 33 |
34901958 | A comparison of the diagnostic performance of 18F-PSMA-1007 and 68GA-PSMA-11 in the same patients presenting with early biochemical recurrence. | 2021 Sep-Dec |
1 |
| 34 |
30773328 | Gallium-68 Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer-Updated Diagnostic Utility, Sensitivity, Specificity, and Distribution of Prostate-specific Membrane Antigen-avid Lesions: A Systematic Review and Meta-analysis. | 2020 Apr |
5 |
| 35 |
31246686 | Low 68Ga-PSMA PET/CT Uptake in Chronic Intramuscular Nodular Fasciitis. | 2020 Jan |
2 |
| 36 |
31348086 | Clinical Utility of 68Ga-Prostate-Specific Membrane Antigen PET/CT Scan on Postoperative Assessment of Juvenile Nasal Angiofibroma. | 2020 Feb |
1 |
| 37 |
31524682 | 68Ga-PSMA-HBED-CC PET/CT and 18F-FDG PET/CT in Ewing Sarcoma. | 2020 Jan |
1 |
| 38 |
31529265 | 68Ga-PSMA I&T PET/CT for primary staging of prostate cancer. | 2020 Jan |
1 |
| 39 |
31714366 | In primary lymph nodal staging of patients with high-risk and intermediate-risk prostate cancer, how critical is the role of Gallium-68 prostate-specific membrane antigen positron emission tomography-computed tomography? | 2020 Feb |
1 |
| 40 |
31845408 | Manual vs automated 68 Ga-radiolabelling-A comparison of optimized processes. | 2020 Apr |
1 |
| 41 |
31957122 | Protocol for the PRIMARY clinical trial, a prospective, multicentre, cross-sectional study of the additive diagnostic value of gallium-68 prostate-specific membrane antigen positron-emission tomography/computed tomography to multiparametric magnetic resonance imaging in the diagnostic setting for men being investigated for prostate cancer. | 2020 Apr |
2 |
| 42 |
32108699 | Incidental Detection of Hypothyroidism on 68Ga-PSMA-HBED-CC PET/CT Imaging. | 2020 Apr |
2 |
| 43 |
32374450 | Automated synthesis of 68 Ga/177 Lu-PSMA on the Trasis miniAllinOne. | 2020 Jun 30 |
1 |
| 44 |
32394269 | Does bone scintigraphy still have a role in the era of 68 Ga-PSMA PET/CT in prostate cancer? | 2020 Jul |
1 |
| 45 |
32404702 | 68Ga-PSMA PET/CT and 18F-FDG PET/CT in Renal Cell Carcinoma. | 2020 Jul |
1 |
| 46 |
32433170 | The Effect of Various β Values on Image Quality and Semiquantitative Measurements in 68Ga-RM2 and 68Ga-PSMA-11 PET/MRI Images Reconstructed With a Block Sequential Regularized Expectation Maximization Algorithm. | 2020 Jul |
1 |
| 47 |
32531840 | 68 Ga-PSMA-PET/CT helps to select patients for salvage radical prostatectomy with local recurrence after primary radiotherapy for prostate cancer. | 2020 Dec |
1 |
| 48 |
32592330 | Solitary rib lesions showing prostate-specific membrane antigen (PSMA) uptake in pre-treatment staging 68 Ga-PSMA-11 positron emission tomography scans for men with prostate cancer: benign or malignant? | 2020 Sep |
2 |
| 49 |
32701807 | 68Ga-Prostate-Specific Membrane Antigen-11-Avid Cardiac Metastases in a Patient With Adenoid Cystic Carcinoma, A Rare Presentation of a Rare Cancer. | 2020 Sep |
1 |
| 50 |
32716402 | Correlations of the 68Ga-PSMA PET/CT derived primary prostate tumor PSMA expression parameters and metastatic patterns in patients with Gleason Score >7 prostate cancer. | 2020 May-Aug |
3 |